APA (7th ed.) Citation

DM, C., HQ, H., W, D., WJ, K., W, R., Jr, S. W., . . . SY, R. (2025). Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263). Gynecologic oncology, 202, 102. https://doi.org/10.1016/j.ygyno.2025.09.014

Chicago Style (17th ed.) Citation

DM, Chase, et al. "Patient-reported Outcomes of a Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Patients Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NRG/GOG-0263)." Gynecologic Oncology 202 (2025): 102. https://doi.org/10.1016/j.ygyno.2025.09.014.

MLA (9th ed.) Citation

DM, Chase, et al. "Patient-reported Outcomes of a Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Patients Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NRG/GOG-0263)." Gynecologic Oncology, vol. 202, 2025, p. 102, https://doi.org/10.1016/j.ygyno.2025.09.014.